An interventional study of Autogenous Dentin Graft and Platelet-Rich Fibrin (PRF) in Tooth Extraction and Alveolar Bone Loss, sponsored by Ankara Yildirim Beyazıt University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.
Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Alveolar Bone Loss with a site in Turkey — 8 open to participants now, 10 under way, none of them phase 3. Alveolar Bone Loss · Turkey.
Among the 33 studies in Alveolar Bone Loss with a site in Turkey, this one is the 19th largest by enrollment of the 20 interventional ones that give a count, is one of 6 that started in 2023, is one of 18 with no phase, and was the 30th registered.
319 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.
Browse Alveolar Bone Loss studies →8 of the 33 studies in Alveolar Bone Loss with a site in Turkey are open now. Recruiting first, the newest first:
Recep Tayyip Erdogan University Training and Research Hospital · Sites in Turkey
Ages 18–65 · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18–65 · Healthy volunteers
Saglik Bilimleri Universitesi · Sites in Turkey
Ages 18–65 · Healthy volunteers
Kutahya Health Sciences University · Sites in Turkey
Ages 18–99 · Healthy volunteers
Istanbul Saglik Bilimleri University · Sites in Turkey
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 47 Alveolar Bone Loss studies recruiting now, 19 (40%) set no upper age limit and 22 (47%) stop at 75 or younger; 4 take children under 18; 24 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 6 started in 2023.
This study's enrollment of 9 is below the median of 25 across 270 interventional studies indexed under Alveolar Bone Loss.
Median enrollment 30 across the 20 interventional studies, 41 across the 13 observational. Of the 22 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 33 has an industry lead sponsor. The 10 most frequent:
Ankara Yildirim Beyazıt University is the lead sponsor of 241 studies on the registry; 54 are open to participants now.
Ankara Yildirim Beyazıt University has 1 study filed under Alveolar Bone Loss — fewer than ten, so there is no comparison to draw.
3 of the studies in Alveolar Bone Loss with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07397884Saglik Bilimleri UniversitesiMarkers of Bone Destruction and Oxidative Stress in Peri-implantitis | 2026-11-15 |
| NCT07146776Saglik Bilimleri UniversitesiTreatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts | 2026-12-01 |
| NCT07907900Ankara UniversityDiagnostic Accuracy of Large Language Models for Peri-Implant Marginal Bone Loss on Panoramic Radiographs | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 33 studies in Alveolar Bone Loss with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
When a tooth is extracted, the bone around the empty socket naturally shrinks over time, which can make it difficult to place a dental implant later without additional bone-building procedures. This study investigated whether grafting the socket with the patient's own extracted tooth material, processed into a graft (autogenous dentin graft), can help preserve this bone. The study also examined whether adding platelet-rich fibrin (PRF), a concentrate prepared from the patient's own blood that is rich in healing factors, could further improve outcomes. A total of 56 extraction sockets were randomly assigned to one of four treatment approaches: no grafting (natural healing), dentin graft alone, dentin graft combined with PRF, or a freeze-dried bone allograft, which is a commonly used bone substitute for comparison. Four months after treatment, small bone samples were taken from each site at the time of dental implant placement and examined under the microscope to measure how much new bone had formed, along with other markers of healing such as blood vessel formation and a bone-growth protein called BMP-2. The results showed that sockets treated with dentin graft healed at least as well as those treated with the standard bone substitute, and that combining dentin graft with PRF produced the best healing results of all groups tested. These findings suggest that a patient's own extracted tooth, which would otherwise be discarded, may serve as an effective and low-cost graft material for preserving bone after tooth extraction, particularly when combined with PRF.
Following tooth extraction, the alveolar ridge undergoes progressive dimensional changes, primarily due to bundle bone resorption, which may compromise the volume and quality of bone available for future implant placement. Alveolar ridge preservation (ARP) procedures aim to minimize this resorption through the use of various grafting materials.
This prospective, randomized, controlled clinical trial was conducted at the Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Ankara Yıldırım Beyazıt University. Eligible participants were systemically healthy individuals aged ≥18 years (ASA I-II) who required extraction of a radiographically non-infected tooth. Patients with acute infection at the extraction site, advanced systemic disease, use of medications affecting bone metabolism, smoking or alcohol consumption, or anticipated non-compliance with follow-up visits were excluded.
A total of 56 extraction sockets from nine patients (six women and three men; age range, 24-55 years) were randomly allocated into four groups: Control (spontaneous healing without grafting, n = 13), Dentin (grafted with autogenous dentin particles, n = 14), Dentin + PRF (grafted with autogenous dentin combined with leukocyte- and platelet-rich fibrin, n = 15), and FDBA (grafted with freeze-dried bone allograft, n = 14). All surgical procedures were performed by the same operator to eliminate inter-operator variability.
The sample size was calculated using G*Power version 3.1.9.6 (Universität Kiel, Germany), based on a repeated-measures ANOVA design, an effect size of 0.20, a statistical power of 80%, and an alpha level of 0.05. The analysis indicated that a minimum of 52 extraction sockets (13 per group) was required.
Autogenous dentin grafts were prepared immediately after extraction according to the method described by Binderman et al. Soft-tissue remnants, enamel, and cementum were removed from the extracted teeth using a tungsten carbide bur under water cooling. The cleaned teeth were processed using a Smart Dentin Grinder (KometaBio, Israel) to obtain particulate graft material with a particle size of 300-1200 µm. The particles were subsequently disinfected for 10 min in a solution containing 20% ethanol and 0.5 M NaOH and rinsed with a buffered saline solution to neutralize the pH before graft placement.
For the Dentin + PRF group, platelet-rich fibrin was prepared from 10 mL of venous blood collected in sterile tubes without anticoagulant and centrifuged at approximately 2700-3000 rpm for 10-12 min according to the Choukroun protocol. The resulting PRF clot was compressed into a membrane, cut into small fragments, and homogeneously mixed with the dentin particles before placement into the extraction sockets.
Full-thickness mucoperiosteal flaps were elevated as required in the Dentin and Dentin + PRF groups, and the graft materials were adapted to ensure close contact with the socket walls. In the FDBA group, the commercially available allograft was placed with minimal or no flap elevation. In the Control group, the extraction sockets were allowed to heal spontaneously through blood clot formation without graft placement or flap surgery. The flaps were closed using 3-0 silk sutures. In selected cases in which primary closure could not be achieved, a free gingival graft was used as a "socket seal." Postoperative care consisted of a standard antibiotic regimen (amoxicillin/clavulanic acid, 1000 mg twice daily for 7 days), an NSAID analgesic, and a chlorhexidine/benzydamine mouth rinse. Sutures were removed on postoperative day 10, and patients were followed clinically at monthly intervals.
Four months after grafting, at the time of dental implant placement, cylindrical bone-core biopsies were obtained from the treated alveolar ridge using a trephine bur. Specimens were fixed in 10% neutral buffered formalin, decalcified in 10% formic acid, and processed for routine histological embedding. Sections (5 µm thick) were stained with hematoxylin and eosin for histomorphometric evaluation of newly formed bone, connective tissue, vascularization, and residual graft particles.
Immunohistochemical staining for bone morphogenetic protein-2 (BMP-2) was performed following antigen retrieval. BMP-2 expression was quantified using a semi-quantitative HSCORE method combining staining intensity (0-3) and the percentage of positively stained cells. Five randomly selected fields per section were evaluated at ×40 magnification independently by two blinded observers.
Statistical analyses were performed using IBM SPSS Statistics version 21. The normality of continuous variables was assessed using the Shapiro-Wilk test. Normally distributed variables were analyzed using one-way ANOVA followed by Bonferroni post hoc comparisons, whereas non-normally distributed variables were analyzed using the Kruskal-Wallis test followed by Bonferroni-corrected Mann-Whitney U tests for pairwise comparisons. A p-value ≤ 0.05 was considered statistically significant.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Extraction sockets were left to heal spontaneously without any graft material, based on natural blood clot formation, with no flap surgery performed.
Extraction sockets were grafted with autogenous dentin particles obtained from the patient's own extracted tooth, processed using the Smart Dentin Grinder device.
Biological: Autogenous Dentin Graft
Extraction sockets were grafted with autogenous dentin particles combined with platelet-rich fibrin (PRF) prepared from the patient's own venous blood.
Biological: Autogenous Dentin Graft · Biological: Platelet-Rich Fibrin (PRF)
Extraction sockets were grafted with a commercial freeze-dried bone allograft (FDBA), used as a standard comparator graft material.
Biological: Freeze-Dried Bone Allograft (FDBA)
Particulate graft material (300-1200 µm) obtained by processing the patient's own extracted tooth using the Smart Dentin Grinder device (KometaBio, Israel), placed into the extraction socket.
Autogenous dentin particles combined with platelet-rich fibrin, prepared by centrifugation of the patient's own venous blood (2700-3000 rpm, 10-12 minutes), placed into the extraction socket.
Commercial freeze-dried bone allograft placed into the extraction socket as a comparator graft material.
Percentage of Newly Formed Bone
Histomorphometric quantification of the percentage of newly formed bone within the grafted extraction socket, assessed on hematoxylin and eosin-stained sections of bone core biopsies obtained at the time of implant placement.
Time frame: 4 months after grafting
Percentage of Connective Tissue Formation
Histomorphometric quantification of the percentage of connective tissue within the bone core biopsy specimens.
Time frame: 4 months after grafting
Vascularization
Histomorphometric assessment of new vessel formation within the bone core biopsy specimens.
Time frame: 4 months after grafting
BMP-2 Immunoexpression (HSCORE)
Semi-quantitative immunohistochemical assessment of bone morphogenetic protein-2 (BMP-2) expression, calculated using the HSCORE method combining staining intensity and percentage of positive cells.
Time frame: 4 months after grafting
Plan to share: No — Individual participant data will not be shared, as this was not specified in the study protocol approved by the institutional ethics committee, and participant consent did not include provisions for external data sharing.
No publications or documents are linked to this record.
Ran from Dec 2023 to primary completion in Apr 2024, 4 months.
Of 168 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's 4 months is below that.
Counting every sponsor, half of 168 studies reached it within 18 months; a quarter within 11 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara Yildirim Beyazıt University →